InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: None

Monday, 04/11/2016 7:55:16 PM

Monday, April 11, 2016 7:55:16 PM

Post# of 233431
Guys check this out. It could have changed since then but Gilead's HIV franchise accounts for 44% of its total revenue. That means if the results from CYDY are top knotch, Gilead won't be able to ignore the company. They will probably negotiate a partnership deal or buyout IMO.

http://www.fool.com/investing/general/2015/01/14/gilead-sciences-inc-is-no-longer-an-hiv-company-so.aspx
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News